For immunohistochemistry and flow cytometry, dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. For functional studies, in vitro dilutions have to be optimized in user's experimental setting. Positive HUVEC and fresh lymphocytes control Negative COS cells (Ref. 2) control
Restrictions
For Research Use only
Buffer
PBS, containing 0.1 % bovine serum albumin.
Stock
4 °C
Stockage commentaire
Product should be stored at 4 °C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
Niemelä, Henttinen, Yegutkin, Airas, Kujari, Rajala, Jalkanen: "IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 172, Issue 3, pp. 1646-53, (2004) (PubMed).
Airas, Niemelä, Jalkanen: "CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 165, Issue 10, pp. 5411-7, (2000) (PubMed).
Airas, Niemelä, Salmi, Puurunen, Smith, Jalkanen: "Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells." dans: The Journal of cell biology, Vol. 136, Issue 2, pp. 421-31, (1997) (PubMed).
Airas, Hellman, Salmi, Bono, Puurunen, Smith, Jalkanen: "CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73." dans: The Journal of experimental medicine, Vol. 182, Issue 5, pp. 1603-8, (1995) (PubMed).
Airas, Salmi, Jalkanen: "Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 151, Issue 8, pp. 4228-38, (1993) (PubMed).
The monoclonal antibody 4G4 recognizes both membrane bound and soluble human CD73, also known as ecto-5'-nucleotidase. CD73 is a 70- kDa GPI-anchored cell surface molecule and belongs to the 5'-nucleosidase family. CD73 is useful as marker for lymphocyte differentiation. It is abundantly expressed on the vascular endothelium and at a low level on certain subpopulations of human lymphocytes. Like many glycosyl-phosphatidylinositol (GPI)-anchored molecules, it transmits potent activation signals in T cells when ligated by antibodies. CD73 hydrolyzes extracellular nucleotides into membrane permeable nucleosides. Ecto-5'-nucleotidase activity is an important mediator of the anti- inflammatory effect by converting extracellular AMP into a potent anti-inflammatory substance adenosine. CD73 has been shown to function as a co-stimulatory molecule in human T cells and to have a role in regulating lymphocyte adhesion. Triggering of CD73 on the surface of lymphocytes, but not on endothelial cells, results in the shedding of the CD73 and increased adhesion of lymphocytes to endothelium via LFA-1 clustering. Furthermore, CD73 has been implicated to mediate homing of skin-infiltrating lymphocytes in vivo. In B-cell chronic lymphocytic leukemia the expression of CD73 is decreased. Besides this, CD73 activity has been implicated as sensitive and useful indicator for mild zinc deficiency. The monoclonal antibody 4G4 causes a reduction in CD73 expression on lymphocytes, reduces enzyme activity, and inhibits the binding of lymphocytes to endothelial cells. Aliases Ecto-5'-nucleotidase, , EC3.1.3.5 Immunogen Inflamed synovial stroma from rheumatoid arthitis patients